market spotlight
AstraZeneca links up with a Hong Kong technology park to develop new cancer diagnostics and treatments.
Hong Kong is Asia’s biggest fund-raising hub for biotechnology, and the world’s second-largest, behind the United States’ Nasdaq. The city would become the world’s number one between 2025 and 2030, according to predictions made last September by the then Chief Executive of the Hong Kong Exchanges and Clearing (HKEX), Charles Li.More
Topics: Medical Supplies & Medicine, Finance & Investment, Hong Kong, Biotech, MedTech
Page of 50